The Wealth Empire report comes out every week,
check your inbox for direct access.
Since June 2017, oil prices rocketed from a low of $42.05 to a high of $64.30 in early 2018.
At the time, that was the highest crude oil prices had been since May 2015 thanks in part to OPEC production cuts. We were also seeing strong demand growth in China, too.
It’s the reason Exxon Mobil (XOM) jumped from a 2017 low of $75 to $87.50. Chevron (CVX) ran from $101 to $133.60. Conoco Phillips (COP) exploded from $42 to $60.
Sometimes, the greatest opportunities are hiding in plain sight.
Yet, they’re ignored, or “left for dead” out of fear that a sector may be too speculative. Biotech and pharmaceutical stocks are the perfect examples. But only the foolish have ignored the rewards the sector has produced -- and will produce.
Controversial or not, one of the hottest investments of 2018 could very well be the marijuana story. In fact, even after some monster moves in the sector, there’s still further upside remaining, as we noted in early December 2017.
At the time, we highlighted opportunities in the following names:
It’s one of the hottest trades on the market.
It’s already outperformed stocks, bonds, gold and real estate. And to be perfectly honest with you, there’s no end in sight.
In January 2013, it priced at just $13.36.
Four and a half years later, it was up to $19,661 – a gain of 147,063% -- before pulling back.